Protagonist Therapeutics Inc buy Truist Financial Co.
Start price
09.09.24
/
50%
€50.50
Target price
09.09.25
€54.34
Performance (%)
4.95%
End price
10.09.25
€53.00
Summary
This prediction ended on 10.09.25 with a price of €53.00. The BUY prediction by Truist_Financial_Co_ finished with a performance of 4.95%. Truist_Financial_Co_ has a follow-up prediction for Protagonist Therapeutics Inc where he still thinks Protagonist Therapeutics Inc is a Buy. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protagonist Therapeutics Inc | 6.723% | 6.723% | 188.636% |
| iShares Core DAX® | 2,57 % | 5,33 % | 8,27 % |
| iShares Nasdaq 100 | 4,86 % | 0,45 % | 27,08 % |
| iShares Nikkei 225® | 5,59 % | -0,59 % | 48,55 % |
| iShares S&P 500 | 3,25 % | 2,50 % | 23,35 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $60.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
In the thread Trading Protagonist Therapeutics Inc
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Truist_Financial_Co_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€66.00
28.10.25
28.10.25
€75.49
28.10.26
28.10.26
92.42%
07.08.26
07.08.26
Stopped prediction by Truist_Financial_Co_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
11.03.25
11.03.25
€70.01
11.03.26
11.03.26
66.34%
12.03.26
12.03.26